— Know what they know.
Not Investment Advice
Also trades as: SBS.DE (XETRA) · $vol 0M · 0RAR.L (LSE) · $vol 0M

STSEY OTC

Stratec SE
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +8.0% 1Y: -17.8% 3Y: -78.5% 5Y: -78.1%
$5.51
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 47 · $1.7B mcap · 33M float · 0.0003% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$258M -1.6% ▼
5Y CAGR: +3.1%
Gross Profit
$76M +17.8% ▲
5Y CAGR: +8.0%
Operating Income
$28M +10.8% ▲
5Y CAGR: +8.1%
Net Income
$16M +22.6% ▲
5Y CAGR: +2.1%
EPS (Diluted)
$0.05 -75.7% ▼
5Y CAGR: -28.1%
EBITDA
$47M +18.6% ▲
5Y CAGR: +5.6%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$250M$287M$275M$262M$258M
YoY Growth+12.8%+14.9%-4.4%-4.6%-1.6%
Cost of Revenue$181M$200M$195M$197M$181M
Gross Profit$69M$88M$79M$65M$76M
Gross Margin27.6%30.5%28.9%24.8%29.7%
R&D Expenses$8M$9M$7M$9M$12M
SG&A Expenses$28M$28M$30M$32M$37M
Operating Expenses$37M$37M$39M$39M$48M
Operating Income$32M$48M$40M$25M$28M
Operating Margin13.0%16.8%14.6%9.7%10.9%
Interest Expense$1M$1M$2M$4M$6M
Income Before Tax$33M$47M$39M$18M$22M
Tax Expense$5M$7M$10M$5M$6M
Net Income$25M$40M$29M$13M$16M
Net Margin10.1%13.9%10.6%5.0%6.2%
EPS (Diluted)$0.47$0.66$0.48$0.21$0.05
EBITDA$53M$65M$55M$40M$47M
Shares Outstanding61M61M61M61M304M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms